Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Oppelt

Showing results (171-180 of 177) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 177 results.
Journal of the National Cancer Institute|June 20, 2013
L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluationAlain G Zeimet, Daniel Reimer, Monica Huszar, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
High-avidity TCR signaling induces a distinct KLR-positive exhaustion state in human tumor-infiltrating CD8 T cells associated with immunotherapy responseRiley D Z Mullins, Jesse M Zaretsky, Thomas F Barrett, et al.
Geburtshilfe Und Frauenheilkunde|April 19, 2021
Diagnosis and Treatment of Endometriosis. Guideline of the DGGG, SGGG and OEGGG (S2k Level, AWMF Registry Number 015/045, August 2020)Stefanie Burghaus, Sebastian D Schäfer, Matthias W Beckmann, et al.
Science Immunology|September 8, 2023
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancerGiacomo Oliveira, Ann Marie Egloff, Alexander B Afeyan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2021
Correction: Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-unrelated Head and Neck Cancer: A Multicenter, Phase II TrialRavindra Uppaluri, Katie M Campbell, Ann Marie Egloff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2020
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II TrialRavindra Uppaluri, Katie M Campbell, Ann Marie Egloff, et al.
Geburtshilfe Und Frauenheilkunde|February 13, 2026
Diagnosis and Therapy of Endometriosis. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/045, April 2025)Stefanie Burghaus, Sebastian D Schäfer, Karl-Jürgen Bär, et al.
Pageof 18

Showing results (171-180 of 177) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 177 results.
Journal of the National Cancer Institute|June 20, 2013
L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluationAlain G Zeimet, Daniel Reimer, Monica Huszar, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
High-avidity TCR signaling induces a distinct KLR-positive exhaustion state in human tumor-infiltrating CD8 T cells associated with immunotherapy responseRiley D Z Mullins, Jesse M Zaretsky, Thomas F Barrett, et al.
Geburtshilfe Und Frauenheilkunde|April 19, 2021
Diagnosis and Treatment of Endometriosis. Guideline of the DGGG, SGGG and OEGGG (S2k Level, AWMF Registry Number 015/045, August 2020)Stefanie Burghaus, Sebastian D Schäfer, Matthias W Beckmann, et al.
Science Immunology|September 8, 2023
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancerGiacomo Oliveira, Ann Marie Egloff, Alexander B Afeyan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2021
Correction: Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-unrelated Head and Neck Cancer: A Multicenter, Phase II TrialRavindra Uppaluri, Katie M Campbell, Ann Marie Egloff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2020
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II TrialRavindra Uppaluri, Katie M Campbell, Ann Marie Egloff, et al.
Geburtshilfe Und Frauenheilkunde|February 13, 2026
Diagnosis and Therapy of Endometriosis. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/045, April 2025)Stefanie Burghaus, Sebastian D Schäfer, Karl-Jürgen Bär, et al.
Pageof 18